Stay updated on Advanced Cancers Nivolumab Immuno-therapy Clinical Trial
Sign up to get notified when there's something new on the Advanced Cancers Nivolumab Immuno-therapy Clinical Trial page.

Latest updates to the Advanced Cancers Nivolumab Immuno-therapy Clinical Trial page
- Check5 days agoChange DetectedA sitewide NIH notice about terminology changes appears above the ClinicalTrials.gov error page, and the footer revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content with a generic error page. This indicates the study details are no longer accessible on the page.SummaryDifference18%

- Check40 days agoChange DetectedThe page's revision label updated from v3.6.6 to v3.7.0, indicating a new version of the study page or its related documentation.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a new build of the site. This is a small software update rather than a change to the study information.SummaryDifference0.0%

- Check61 days agoChange DetectedThe study's identifiers now include an NIH grant/contract reference (2016), adding funding attribution to the record for NCT02832167.SummaryDifference0.0%

Stay in the know with updates to Advanced Cancers Nivolumab Immuno-therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Advanced Cancers Nivolumab Immuno-therapy Clinical Trial page.